LIGAND PHARMACEUTICALS INCORPORATED Effective Income Tax Rate Reconciliation Fdii Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Effective Income Tax Rate Reconciliation Fdii Amount of $314.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation fdii amount for fiscal 2025 was $314.00K, a 62.26% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation fdii amount for fiscal 2024 was $832.00K, a 19.77% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation fdii amount for fiscal 2023 was $1.04M, a 56.70% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation fdii amount for fiscal 2022 was $2.40M, a 275.98% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation Fdii Amount 12 month |
|---|---|
| 2025-12-31 | $314.00K 10-K · filed 2026-02-27 |
| 2024-12-31 | $832.00K 10-K · filed 2026-02-27 |
| 2023-12-31 | $1.04M 10-K · filed 2026-02-27 |
| 2022-12-31 | $2.40M 10-K · filed 2025-02-28 |
| 2021-12-31 | $637.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $1.65M 10-K · filed 2023-02-28 |